Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
WHO Backs Pfizer’s Paxlovid For High-Risk COVID-19 Patients
But Access Obstacles Remain In Lower-Income Countries
Apr 22 2022
•
By
Ian Schofield
The WHO has updated its "living guidance" on COVID-19 drugs • Source: Alamy
More from International
More from Geography